Astellas Pharma GmbH
- Pharmaceutical Sales 2007
-
Worldwide: 6.2 billion Euro
Germany: above 200 million Euro
- Product Range
- Immun suppressive agents in transplantation, dermatology, COPD, Asthma, antimycotics, urology
- Key Research Areas
- Transplantation, Urology, Viral and Bacterial Infectiology, Immunology, Oncology, Diabetes mellitus, CNS-related Diseases. Hematology, Pain
- R&D Expenditure 2007
-
Worldwide: 1.3 billion US-Dollars
- Employees in the Pharmaceuticals Division 2008
-
Worldwide: approx. 14,000
Germany: approx. 400
(All data based on corporate information, as of: 04/2009)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page